-
1
-
-
0035306941
-
Clinical trials of vascular brachytherapy for in-stent restenosis: Update
-
Ajani AE, Kim HS, Waksman R. Clinical trials of vascular brachytherapy for in-stent restenosis: update. Cardiovasc Radiat Med. 2001;2:107-113.
-
(2001)
Cardiovasc Radiat Med
, vol.2
, pp. 107-113
-
-
Ajani, A.E.1
Kim, H.S.2
Waksman, R.3
-
2
-
-
0034008545
-
Restenosis after percutaneous coronary intervention and infection
-
Herzum M, Schaefer JR, Simon B, Menz V, Noll B, Maisch B. Restenosis after percutaneous coronary intervention and infection. Herz. 2000;25:91-94.
-
(2000)
Herz
, vol.25
, pp. 91-94
-
-
Herzum, M.1
Schaefer, J.R.2
Simon, B.3
Menz, V.4
Noll, B.5
Maisch, B.6
-
3
-
-
0027934377
-
A randomized comparison of coronary-stent replacement and balloon angioplasty in the treatment of coronary artery disease
-
Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent replacement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
-
(1994)
N Engl J Med
, vol.331
, pp. 496-501
-
-
Fischman, D.L.1
Leon, M.B.2
Baim, D.S.3
-
4
-
-
0028123099
-
A comparison of the balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
-
Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of the balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
-
(1994)
N Engl J Med
, vol.331
, pp. 489-495
-
-
Serruys, P.W.1
De Jaegere, P.2
Kiemeneij, F.3
-
5
-
-
0032480946
-
Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty
-
Erbel R, Haude M, Hopp HW, et al. Coronary artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med. 1998;339:1672-1678.
-
(1998)
N Engl J Med
, vol.339
, pp. 1672-1678
-
-
Erbel, R.1
Haude, M.2
Hopp, H.W.3
-
6
-
-
0037180418
-
Coated stents for the prevention of restenosis
-
Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis. Circulation. 2002;106:2859-2866.
-
(2002)
Circulation
, vol.106
, pp. 2859-2866
-
-
Babapulle, M.N.1
Eisenberg, M.J.2
-
7
-
-
0141765805
-
Sirolimus-eluting stents verses standard stents in patients with stenosis in a native coronary artery
-
Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents verses standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
-
(2003)
N Engl J Med
, vol.349
, pp. 1315-1323
-
-
Moses, J.W.1
Leon, M.B.2
Popma, J.J.3
-
8
-
-
0038299000
-
Sirolimus: Its discovery, biological properties and mechanism of action
-
Sehgal SN. Sirolimus: its discovery, biological properties and mechanism of action. Transplant Proc. 2003;35(suppl 1):7S-14S.
-
(2003)
Transplant Proc
, vol.35
, Issue.SUPPL. 1
-
-
Sehgal, S.N.1
-
9
-
-
0032105481
-
Rapammume (RAPA, sirolimus): Mechanism of action. Immunosuppressive effects results from blockade if signal transduction and inhibition of cell cycle progression
-
Sehgal SN. Rapammume (RAPA, sirolimus): mechanism of action. Immunosuppressive effects results from blockade if signal transduction and inhibition of cell cycle progression. Clin Biochem. 1998;31:335-340.
-
(1998)
Clin Biochem
, vol.31
, pp. 335-340
-
-
Sehgal, S.N.1
-
10
-
-
33444474128
-
-
Abbott Laboratories, Internal Scientific Report No. R&D/02/386. Abbott Park, Ill: Abbott Laboratories
-
Chen Y, Gintant GA, Cox BF, Sullivan J. Comparison of Potencies of ABT-578 and Rapamycin in Inhibiting Human Coronary Artery Smooth Muscle Cell Proliferation. Abbott Laboratories, Internal Scientific Report No. R&D/02/386. Abbott Park, Ill: Abbott Laboratories; 2002.
-
(2002)
Comparison of Potencies of ABT-578 and Rapamycin in Inhibiting Human Coronary Artery Smooth Muscle Cell Proliferation
-
-
Chen, Y.1
Gintant, G.A.2
Cox, B.F.3
Sullivan, J.4
-
11
-
-
33444472970
-
-
Abbott Laboratories, Internal Scientific Report No. 51R-002-AP-03-R1. Abbott Park, Ill: Abbott Laboratories
-
Chen Y, Burke S, Toner J. Comparative Potency of ABT-578, Sirolimus, Everolimus, Tacrolimus, Paclitaxel, and Dexamethasone in Inhibiting Human Coronary Artery Smooth Muscle Cell Proliferation In Vitro. Abbott Laboratories, Internal Scientific Report No. 51R-002-AP-03-R1. Abbott Park, Ill: Abbott Laboratories; 2004.
-
(2004)
Comparative Potency of ABT-578, Sirolimus, Everolimus, Tacrolimus, Paclitaxel, and Dexamethasone in Inhibiting Human Coronary Artery Smooth Muscle Cell Proliferation in Vitro
-
-
Chen, Y.1
Burke, S.2
Toner, J.3
-
12
-
-
33444473224
-
-
ABT-578, paclitaxel, and rapamycin-eluting stents show similar efficacy in a porcine model of coronary restenosis. Poster presented; March; Washington, DC
-
Burke SE, Toner JL, Cromack KR, et al. ABT-578, paclitaxel, and rapamycin-eluting stents show similar efficacy in a porcine model of coronary restenosis. Poster presented at: Annual Meeting of Cardiovascular Revascularization Therapies (CRT); March 2005; Washington, DC.
-
(2005)
Annual Meeting of Cardiovascular Revascularization Therapies (CRT)
-
-
Burke, S.E.1
Toner, J.L.2
Cromack, K.R.3
-
13
-
-
2042441795
-
96-Well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples
-
Ji QC, Reimer TM, El-Shourbagy TA. 96-Well liquid-liquid extraction liquid chromatography-tandem mass spectrometry method for the quantitative determination of ABT-578 in human blood samples. J. Chromatogr B. 2004;805:67-75.
-
(2004)
J. Chromatogr B
, vol.805
, pp. 67-75
-
-
Ji, Q.C.1
Reimer, T.M.2
El-Shourbagy, T.A.3
-
14
-
-
0003571561
-
-
Columbus, Ohio: McGraw-Hill
-
Braunwald E, Fauci A, Kasper D, Hauser S, Longo D, Jameson J. Harrison's Principles of Internal Medicine. Columbus, Ohio: McGraw-Hill; 2004.
-
(2004)
Harrison's Principles of Internal Medicine
-
-
Braunwald, E.1
Fauci, A.2
Kasper, D.3
Hauser, S.4
Longo, D.5
Jameson, J.6
-
16
-
-
33444475085
-
Safety and pharniacokinetics of single, escalating, intravenous doses of ABT-578 in healthy male subjects
-
Palaparthy R, Pradhan RS, Chan J, et al. Safety and pharniacokinetics of single, escalating, intravenous doses of ABT-578 in healthy male subjects [abstract]. AAPS J. 2004;6:M1096.
-
(2004)
AAPS J
, vol.6
-
-
Palaparthy, R.1
Pradhan, R.S.2
Chan, J.3
-
19
-
-
33444464952
-
-
Internal Scientific Report No. R&D/03/366. Abbott Park, Ill: Drug Metabolism Division, Abbott Laboratories
-
Murray B, Medina C, Guan Z, et al. The Metabolism, Excretion and Tissue Distribution of [14C] Abbott-179578 in Rabbits. Internal Scientific Report No. R&D/03/366. Abbott Park, Ill: Drug Metabolism Division, Abbott Laboratories; 2002.
-
(2002)
The Metabolism, Excretion and Tissue Distribution of [14C] Abbott-179578 in Rabbits
-
-
Murray, B.1
Medina, C.2
Guan, Z.3
|